Citizens Financial Group Inc. RI Makes New $276,000 Investment in GE HealthCare Technologies Inc. $GEHC

Citizens Financial Group Inc. RI purchased a new stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 3,729 shares of the company’s stock, valued at approximately $276,000.

Other large investors have also recently modified their holdings of the company. N.E.W. Advisory Services LLC purchased a new stake in GE HealthCare Technologies during the 1st quarter valued at about $25,000. Allianz SE lifted its position in GE HealthCare Technologies by 165.2% in the second quarter. Allianz SE now owns 350 shares of the company’s stock valued at $26,000 after purchasing an additional 218 shares during the last quarter. Gladwyn Financial Advisors Inc. purchased a new stake in shares of GE HealthCare Technologies during the second quarter valued at approximately $34,000. Game Plan Financial Advisors LLC grew its holdings in shares of GE HealthCare Technologies by 295.3% in the second quarter. Game Plan Financial Advisors LLC now owns 502 shares of the company’s stock worth $37,000 after purchasing an additional 375 shares during the last quarter. Finally, Zions Bancorporation National Association UT purchased a new position in shares of GE HealthCare Technologies in the first quarter worth $42,000. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Price Performance

NASDAQ GEHC opened at $72.31 on Thursday. The stock has a market capitalization of $32.94 billion, a price-to-earnings ratio of 14.94, a PEG ratio of 2.97 and a beta of 1.13. The company has a debt-to-equity ratio of 0.83, a current ratio of 1.18 and a quick ratio of 0.95. The business’s fifty day moving average price is $74.77 and its 200-day moving average price is $73.76. GE HealthCare Technologies Inc. has a 1-year low of $57.65 and a 1-year high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.05 by $0.02. The company had revenue of $5.14 billion during the quarter, compared to analyst estimates of $5.07 billion. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. The firm’s quarterly revenue was up 5.8% compared to the same quarter last year. During the same period in the previous year, the business posted $1.14 earnings per share. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. On average, equities analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, November 14th. Investors of record on Friday, October 24th were given a dividend of $0.035 per share. The ex-dividend date was Friday, October 24th. This represents a $0.14 annualized dividend and a yield of 0.2%. GE HealthCare Technologies’s payout ratio is 2.89%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on GEHC shares. Barclays began coverage on shares of GE HealthCare Technologies in a report on Monday, October 13th. They set an “equal weight” rating and a $86.00 price target for the company. Evercore ISI increased their target price on shares of GE HealthCare Technologies from $88.00 to $92.00 and gave the stock an “outperform” rating in a report on Thursday, October 30th. Zacks Research cut GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 29th. Wall Street Zen lowered GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, September 20th. Finally, BTIG Research set a $87.00 target price on GE HealthCare Technologies in a research note on Wednesday, October 29th. Six investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $86.10.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.